Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia.
暂无分享,去创建一个
C. Mullighan | K. Roberts | Kathleen W. Rao | M. Hayden | B. Weston | George D Fedoriw | S. Bowyer | Johann Hsu | George Fedoriw | K. Rao